Epic Medical Research

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes3 trials
• Obstructive sleep apnoea2 trials
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Gastroparesis1 trial
• Gout1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 1 diabetes1 trial

Phase

• Phase 35 trials
• Phase 24 trials

Status

• Recruiting6 trials
• Active, not recruiting2 trials
• Completed2 trials
• Not yet recruiting1 trial

Lead sponsor

• Novo Nordisk A/S4 trials
• CinDome Pharma, Inc.1 trial
• Crystalys Therapeutics1 trial
• Endogenex, Inc.1 trial
• HighTide Therapeutics (Hong Kong) Limited1 trial
• and 3 more

Running trials

• Recruiting

  A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease

  NCT07839936· Phase 2· Verve Therapeutics, Inc.· Source

• Recruiting

  A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  NCT07668414· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

  NCT07535034· Phase 2· Crystalys Therapeutics· Source

  Contact: Haresh Boghara, MD

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571005· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

  NCT06267391· Endogenex, Inc.· Source

• Recruiting

  The RESET System Pivotal Clinical Trial (Protocol Revision K)

  NCT04101669· Morphic Medical Inc.· Source

  Contact: Josie Propheter

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity4 recruiting
• Obstructive sleep apnoea2 recruiting
• Coronary artery disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Gout1 recruiting
• Peripheral artery disease1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

  NCT06899217· Phase 2· CinDome Pharma, Inc.· Source

• Completed

  HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

  NCT05623189· Phase 2· HighTide Therapeutics (Hong Kong) Limited· Source